ISSN: 2329-8790
+44 1478 350008
Alan G Rosmarin
Department Medicine, Division of Hematology/Oncology, UMass Memorial Medical Center, University of Massachusetts Medical School, Worcester, MA, USA
Acute myelogenous leukemia; CD25; Prognosis; Relapse